谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

CPGJ602 plus mFOLFOX6 as first-line treatment for patients with KRAS/NRAS/BRAF wild-type metastatic colorectal cancer: A randomized phase II study.

Jianming Xu,Bangwei Cao,Kangsheng Gu,Yuxian Bai,Wei Li,Jingdong Zhang,Caigang Liu,Zuoxing Niu,Liangming Zhang,Haijun Zhong,Suxia Luo,Jian-Wei Zhou,Tianshu Liu,Yanhong Gu,Jingguan Lin,Yanhong Deng,Chuangqi Chen,Yunfeng Li,Xiuli Yang,Bihui Li

Journal of Clinical Oncology（2022）

引用 0|浏览40
暂无评分
关键词
metastatic colorectal cancer,colorectal cancer,mfolfox6,first-line,wild-type
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要